David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center has participated in 30 clinical trials with 19 currently active.
Therapeutic areas: Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer.
Sponsors: Debiopharm International SA, BicycleTx Limited, Coherus Oncology, Inc..
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center has 30 clinical trials on record, with 19 currently active. Their work covers Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer.
Yes — David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.